Frabex Injection

About Frabex 250 mg/5 ml Injection

Frabex Injection contains tranexamic acid, a medicine that helps slow down the breakdown of blood clots so that bleeding can be controlled. It belongs to a group called anti-fibrinolytic drugs and is given by a healthcare professional.

There are 35 brands of Tranexamic Acid listed in Bangladesh. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.

What is Frabex 250 mg/5 ml Injection?

Frabex Injection is a tranexamic acid product made by Square Pharmaceuticals PLC. Tranexamic acid works by blocking the processes that dissolve blood clots, which helps the body hold a clot in place and reduce bleeding. Because it comes as an injection, it is given by a doctor or nurse, usually in a hospital or clinic setting. Doctors use this kind of medicine in certain bleeding problems and around some operations. The dose and course are decided by the doctor based on the patient's condition.

Uses of Frabex

Frabex Injection is used in medical and surgical situations where bleeding needs to be prevented or controlled. Doctors may use it for bleeding linked to certain lung, digestive and blood conditions, and during operations of various types. It can also be used when bleeding problems arise during clot-dissolving therapy or transfusion. Only a doctor can decide whether it is suitable for a particular patient.

How to use Frabex

Frabex Injection 250 mg/5 ml is given by a doctor or nurse as an injection, not by the patient at home. The route, dose and course are decided by the doctor. Tell the doctor about all other medicines you take, because mixing tranexamic acid with some solutions or drugs is not advised. Do not attempt to use it yourself, and ask the doctor or pharmacist if you have questions about how it is given.

Side effects of Frabex

Many people tolerate tranexamic acid well, but some side effects can occur. Reported effects include tiredness, eye irritation, a blocked nose, itching, skin redness and rash. Some people may feel sick, have diarrhoea or stomach burning. A fall in blood pressure on standing has been reported rarely. If you notice any reaction, tell the doctor or nurse straight away so it can be checked.

Safety and precautions

Frabex Injection should not be used by anyone with a known allergy to tranexamic acid, and it is not suitable for people with certain clotting or bleeding conditions or serious kidney problems. It is not to be given during pregnancy unless the doctor decides it is needed, and it passes into breast milk in small amounts. Tell the doctor about kidney problems, a history of clots, or other medicines you take, especially oestrogen-containing products and clot-dissolving drugs. The doctor will decide if it is right for you.

Frequently asked questions

What kind of medicine is Frabex Injection and what is it used for?

It is an anti-fibrinolytic injection containing tranexamic acid. It is used in certain medical and surgical situations to help prevent or control bleeding. A doctor decides whether it is appropriate for a patient.

Which medicines may interact with Frabex Injection?

Tranexamic acid is not compatible with solutions containing penicillins, and clot-dissolving drugs such as streptokinase and urokinase can oppose its action. Oestrogen-containing medicines like oral contraceptives may raise the chance of clot formation. Tell the doctor about every medicine you take.

Who should avoid Frabex Injection or ask the doctor first?

People with a known allergy to tranexamic acid, certain clotting or bleeding conditions, or serious kidney problems should not use it. Anyone who is pregnant or breastfeeding, or who has kidney problems or a history of clots, should speak to the doctor first.

How is Frabex Injection given?

It is given by a doctor or nurse as an injection, usually in a hospital or clinic. The route, dose and length of treatment are decided by the doctor. Do not try to use it yourself, and ask the doctor or pharmacist about anything you are unsure of.

Indications

In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.

In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.

In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.

In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.

In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.

In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.

Pharmacology

This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.

The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.

Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.

Dosage & Administration

Adults-
  • The usual dose: 500-1000 mg 3 times daily.
  • For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
  • For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
Children-
  • For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
  • For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Elderly patients: No reduction in dosage is necessary unless there is evidence of renal failure.

Interaction

Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.

Contraindications

Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.

Side Effects

  • Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
  • After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
  • There are rare cases of postural hypotension.
  • In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.

Pregnancy & Lactation

Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.

Precautions & Warnings

  • Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
  • The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
  • In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
  • Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
  • The administration of product requires particular care in cardiopathic and hepatopathic subjects.

Storage Conditions

Store in a dry place at 15-30°C, away from light and keep out of children's reach.

Alternative brands of Tranexamic Acid

Other brands with the same generic name, cheapest first.

Anaxyl Capsule

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

Anaxyl Tablet

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

See all 35 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.